| Name | Title | Contact Details |
|---|
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
CitiMed is a healthcare provider with over 100 board certified healthcare providers offering a full range of medical services, including primary care, neurosurgery, and pain management, with 20 locations in Queens, the Bronx, and White Plains.
Winter Park Health Foundation is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Winter Park, FL. To find more information about Winter Park Health Foundation, please visit www.wphf.org
LifeScape is a non-profit organization that provides a wide variety of services to empower children and adults with disabilities and medical rehabilitation needs to lead fulfilling lives.
PinnacleCare International is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Baltimore, MD. To find more information about PinnacleCare International, please visit www.pinnaclecare.com